加载中
NASDAQHealthcareMedical - Healthcare Information Services
最新数据
US$7.22
−US$0.19 · -2.56%
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
前收盘价
US$7.22
−US$0.19 · -2.56%
盘后
US$7.35
+US$0.13 · +1.80%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
日内区间
当前US$7.22
52周区间
当前US$7.22
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
69
低估
情绪
50
多空交织
风险
46
风险偏高
动量
79
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
日内区间
当前US$7.22
52周区间
当前US$7.22
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 7727.1万 USD | 6517.3万 USD | 6237.1万 USD | 4756万 USD | 4045万 USD |
| 销货成本 | 2945.7万 USD | 2123.6万 USD | 1945.8万 USD | 1630.6万 USD | 1522.9万 USD |
| 毛利 | 4781.4万 USD | 4393.7万 USD | 4291.3万 USD | 3125.4万 USD | 2522.1万 USD |
| 研究与开发 | 3356.7万 USD | 3436.6万 USD | 3696.9万 USD | 3537.1万 USD | 2657.8万 USD |
| 销售、一般及管理费用 | 8517.2万 USD | 7632.2万 USD | 8172.4万 USD | 8408.3万 USD | 7024万 USD |
| 营业费用 | 1.19亿 USD | 1.11亿 USD | 1.18亿 USD | 1.19亿 USD | 9671万 USD |
| 利息收入 | 187.2万 USD | 336.2万 USD | 454.7万 USD | 132.4万 USD | 2万 USD |
| 利息支出 | 455.4万 USD | 191.3万 USD | 58.8万 USD | 63.9万 USD | 65.8万 USD |
| 折旧和摊销 | 952.9万 USD | 859.6万 USD | 833.6万 USD | 557.1万 USD | 360.9万 USD |
| 营业利润 | −7092.5万 USD | −6656.8万 USD | −7482.6万 USD | −8782.3万 USD | −7148.9万 USD |
| 净利润 | −7899.9万 USD | −6249.3万 USD | −7898.1万 USD | −8744.9万 USD | −7367.5万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
Fidelity Nasdaq Composite Index ETFONEQ42.49万—109.4亿 USD0.21%US$107.36-0.42%
State Street SPDR S&P International Small Cap ETFGWX33.97万0.04%9.15亿 USD0.40%US$45.26-0.66%
Harbor Health Care ETF (MEDI)MEDI17.98万0.43%4144.63万 USD0.80%US$32.35-0.34%
Acuitas Small Cap Active ETFAIMS14.82万0.18%8393万 USD0.75%US$27.06-0.11%
Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETFGNMX7313.670.56%128.63万 USD0.35%US$37.29-0.60%Fidelity Nasdaq Composite Index ETFONEQState Street SPDR S&P International Small Cap ETFGWXHarbor Health Care ETF (MEDI)MEDIAcuitas Small Cap Active ETFAIMSCorgi ETF Trust I - Corgi Genomics & Precision Medicine ETFGNMXAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
